Us Bancorp \De\ Ginkgo Bioworks Holdings, Inc. Transaction History

Us Bancorp \De\

12 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 06, 2024	SELL	$0.28 - $1.16 $32,763 - $135,732	-117,011 Reduced 38.39%	187,786 $61,000
Q1 2024 May 07, 2024	SELL	$1.06 - $1.67 $19,045 - $30,004	-17,967 Reduced 5.57%	304,797 $353,000
Q4 2023 Feb 09, 2024	BUY	$1.26 - $1.79 $161,200 - $229,007	127,937 Added 65.67%	322,764 $545,000
Q3 2023 Nov 03, 2023	BUY	$1.61 - $2.54 $5,834 - $9,204	3,624 Added 1.9%	194,827 $352,000
Q2 2023 Aug 09, 2023	SELL	$1.14 - $1.95 $108,431 - $185,474	-95,115 Reduced 33.22%	191,203 $355,000
Q1 2023 May 09, 2023	BUY	$1.2 - $2.19 $505 - $921	421 Added 0.15%	286,318 $380,000
Q4 2022 Feb 13, 2023	SELL	$1.63 - $3.52 $118,013 - $254,851	-72,401 Reduced 20.21%	285,897 $483,000
Q3 2022 Oct 27, 2022	SELL	$0.73 - $3.74 $69,238 - $354,727	-94,847 Reduced 20.93%	358,298 $1.12 Million
Q2 2022 Aug 01, 2022	BUY	$2.2 - $4.2 $448,175 - $855,607	203,716 Added 81.67%	453,145 $1.08 Million
Q1 2022 May 11, 2022	BUY	$2.83 - $8.69 $705,884 - $2.17 Million	249,429 New	249,429 $1.01 Million
Q4 2021 Feb 11, 2022	SELL	$8.31 - $14.92 $66,480 - $119,360	-8,000 Closed	0 $0
Q3 2021 Nov 10, 2021	BUY	$9.15 - $13.28 $73,200 - $106,240	8,000 New	8,000 $93,000

48.1M

Ticker DNA
Exchange NYSE
Sector Healthcare
Industry Biotechnology
Shares Outstandng 1,287,779,968
Market Cap $10.2B
Description
Ginkgo Bioworks Holdings, Inc., together with its subsidiaries, develops platform for cell programming. Its platform is used to program cells to enable biological production of products, such as novel therapeutics, food ingredients, and chemicals derived from petroleum. The company serves various end markets, including specialty chemicals, agric...

Get notified when there are updates to the investment portfolio of Us Bancorp \De\, based on Form 13F filings with the SEC.

Stay updated on Us Bancorp \De\ with notifications on news.